RA-DLBCL patients with high expression of PD-L1 in tumor cells had shorter OS compared to the patients with low PD-L1 expression in tumor cells (Figure 4) (univariate HR of 2.43 (95% CI, 1.07–5.50)). This evidence concerns the gene CD274 and rheumatoid arthritis.